Publication | Closed Access
Antitumor Agents, 65. Brusatol and Cleomiscosin-A, Antileukemic Principles from Brucea javanica
43
Citations
0
References
1984
Year
Occupational Health SciencesImmunologyAltmetric Attention ScoreBibliometricsPharmacotherapyAntimicrobial ChemotherapyBrucea JavanicaImpact FactorTumor BiologyAltmetricsMedicinal ChemistryAntitumor AgentsToxicologyAnti-cancer AgentPublic HealthDiagnostic SciencesSocial Media PresencePharmacologyEpidemiologyAntileukemic PrinciplesDonut IconMedicineDrug Discovery
ADVERTISEMENT RETURN TO ISSUEPREVArticleNEXTAntitumor Agents, 65. Brusatol and Cleomiscosin-A, Antileukemic Principles from Brucea javanicaKuo-Hsiung Lee, Nanao Hayashi, Masayoshi Okano, Hiroshi Nozaki, and Motoharu Ju-ichiCite this: J. Nat. Prod. 1984, 47, 3, 550–551Publication Date (Print):May 1, 1984Publication History Published online1 July 2004Published inissue 1 May 1984https://pubs.acs.org/doi/10.1021/np50033a030https://doi.org/10.1021/np50033a030research-articleACS PublicationsRequest reuse permissionsArticle Views377Altmetric-Citations34LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose Get e-Alerts